Neuralink Brain Chip
-
{
- All
- News
- Videos
- Web Stories
-
UK Man Using Elon Musk's Neuralink Brain Chip Says It "Feels Magical"
The trial, part of Neuralink's PRIME study, involves 21 participants worldwide with severe paralysis.
-
Elon Musk's Neuralink to Test Brain Chips in Clinical Study in Great Britain
Elon Musk's brain implant company Neuralink said on Thursday it will launch a clinical study in Great Britain to test how its chips can enable patients with severe paralysis to control digital and physical tools with their thoughts.
-
Paralysed Neuralink Patient Writes Name Using Her Thoughts, Elon Musk Responds
Neuralink is a neurotechnology company founded by Elon Musk in 2016 to develop advanced brain-computer interfaces (BCIs).
-
Neuralink Device Helps Monkey See Something That’s Not There
Neuralink's "Blindsight" brain implant is said to have enabled a monkey to perceive non-existent objects, a step toward aiding the blind. Engineer Joseph O'Doherty stated the device stimulated visual brain areas, prompting eye movements towards "visualised" targets two-thirds of the time. Neuralink's first public data on Blindsight, a chip mimickin...
-
Neuralink Brain Chip Implanted In 3rd Patient, Elon Musk Says "Working Well"
Neuralink's brain-computer device has been implanted in a third patient and the company has plans for about 20 to 30 more implants in 2025, Elon Musk said.
-
Elon Musk’s Neuralink Cleared to Start Brain Chip Trial in Canada
Toronto Western Hospital would be the first non-US site of a trial for a device created by Neuralink Corp. Neuralink’s first product aims to allow patients to control external devices, such as computers, through their thoughts.
-
Neuralink's First Patient Names His Brain Chip "Eve", Uses It To Learn Math And Languages
He also has ambitions to finish his degree, start a charity, and build his parents a house one day.
-
Neuralink Brain Chip Implant Wires Now Stable in First Patient, Musk Hopes for More Human Trials This Year
Neuralink's first brain chip implant in a human has stabalised, company executives have confirmed this week. The device works by using tiny wires, which are thinner than a human hair, to capture signals from the brain and translate those into actions such as moving a mouse cursor on a computer screen.
-
Elon Musk's Neuralink Brain Chip Implant "More Or Less Stable" In 1st Patient
The tiny wires of Neuralink's brain chip implant used in the first participant in a trial run by Elon Musk's company have become "more or less very stable", a company executive said on Wednesday.
-
US FDA Clears Neuralink's Brain Chip Implant in Second Patient: Report
The US Food and Drug Administration has allowed billionaire Elon Musk's Neuralink to implant its brain chip in a second person after the company offered fixes to a problem that occurred in the first patient, the Wall Street Journal reported on Monday.
![Gadgets 360 With Technical Guruji: Did You Know? [May 25, 2024]](https://c.ndtvimg.com/2024-01/5oeiv1lo_did-you-know_640x480_20_January_24.jpg?downsize=245:163 "Gadgets 360 With Technical Guruji: Did You Know? [May 25, 2024]")
![Gadgets 360 With Technical Guruji: News of the Week [February 3, 2024]](https://c.ndtvimg.com/2024-02/kjsagne4_news-of-the-week_640x480_03_February_24.jpg?downsize=245:163 "Gadgets 360 With Technical Guruji: News of the Week [February 3, 2024]")
-
UK Man Using Elon Musk's Neuralink Brain Chip Says It "Feels Magical"
The trial, part of Neuralink's PRIME study, involves 21 participants worldwide with severe paralysis.
-
Elon Musk's Neuralink to Test Brain Chips in Clinical Study in Great Britain
Elon Musk's brain implant company Neuralink said on Thursday it will launch a clinical study in Great Britain to test how its chips can enable patients with severe paralysis to control digital and physical tools with their thoughts.
-
Paralysed Neuralink Patient Writes Name Using Her Thoughts, Elon Musk Responds
Neuralink is a neurotechnology company founded by Elon Musk in 2016 to develop advanced brain-computer interfaces (BCIs).
-
Neuralink Device Helps Monkey See Something That’s Not There
Neuralink's "Blindsight" brain implant is said to have enabled a monkey to perceive non-existent objects, a step toward aiding the blind. Engineer Joseph O'Doherty stated the device stimulated visual brain areas, prompting eye movements towards "visualised" targets two-thirds of the time. Neuralink's first public data on Blindsight, a chip mimickin...
-
Neuralink Brain Chip Implanted In 3rd Patient, Elon Musk Says "Working Well"
Neuralink's brain-computer device has been implanted in a third patient and the company has plans for about 20 to 30 more implants in 2025, Elon Musk said.
-
Elon Musk’s Neuralink Cleared to Start Brain Chip Trial in Canada
Toronto Western Hospital would be the first non-US site of a trial for a device created by Neuralink Corp. Neuralink’s first product aims to allow patients to control external devices, such as computers, through their thoughts.
-
Neuralink's First Patient Names His Brain Chip "Eve", Uses It To Learn Math And Languages
He also has ambitions to finish his degree, start a charity, and build his parents a house one day.
-
Neuralink Brain Chip Implant Wires Now Stable in First Patient, Musk Hopes for More Human Trials This Year
Neuralink's first brain chip implant in a human has stabalised, company executives have confirmed this week. The device works by using tiny wires, which are thinner than a human hair, to capture signals from the brain and translate those into actions such as moving a mouse cursor on a computer screen.
-
Elon Musk's Neuralink Brain Chip Implant "More Or Less Stable" In 1st Patient
The tiny wires of Neuralink's brain chip implant used in the first participant in a trial run by Elon Musk's company have become "more or less very stable", a company executive said on Wednesday.
-
US FDA Clears Neuralink's Brain Chip Implant in Second Patient: Report
The US Food and Drug Administration has allowed billionaire Elon Musk's Neuralink to implant its brain chip in a second person after the company offered fixes to a problem that occurred in the first patient, the Wall Street Journal reported on Monday.
